First Horizon Advisors, Inc. Dyne Therapeutics, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.81 Billion
- Q2 2025
A detailed history of First Horizon Advisors, Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 371 shares of DYN stock, worth $4,299. This represents 0.0% of its overall portfolio holdings.
Number of Shares
371
Previous 134
176.87%
Holding current value
$4,299
Previous $1,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DYN
# of Institutions
218Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$120 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$113 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$106 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$85.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$85.6 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $600M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...